For the quarter ending 2026-03-31, COGT has $903,006K in assets. $295,313K in debts. $241,208K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 241,208 | 312,012 | 125,297 | 127,598 |
| Short-term marketable securities | 625,170 | 588,753 | 265,593 | 110,250 |
| Prepaid expenses and other current assets | 11,425 | 9,590 | 6,354 | 7,160 |
| Total current assets | 877,803 | 910,355 | 397,244 | 245,008 |
| Operating lease, right-of-use assets | 17,549 | 18,078 | 18,591 | 19,097 |
| Property and equipment, gross | - | 14,136 | - | - |
| Accumulated depreciation | - | 8,679 | - | - |
| Property and equipment, net | 5,298 | 5,457 | 5,274 | 5,850 |
| Restricted cash | 416 | 416 | 336 | - |
| Other assets | 1,940 | 3,301 | 4,488 | 4,862 |
| Total assets | 903,006 | 937,607 | 425,933 | 274,817 |
| Accounts payable | 13,744 | 9,504 | 16,029 | 16,625 |
| Accrued expenses and other current liabilities | 42,854 | 52,902 | 44,511 | 40,139 |
| Operating lease liabilities | 1,383 | 1,547 | 1,706 | 1,658 |
| Total current liabilities | 57,981 | 63,953 | 62,246 | 58,422 |
| Long-term debt, net | - | - | 44,250 | 43,949 |
| Convertible senior notes, net | 223,173 | 222,895 | - | - |
| Operating lease liabilities, net of current portion | 14,097 | 14,355 | 14,603 | 15,051 |
| Other liabilities | 62 | 33 | 2,370 | 2,359 |
| Total liabilities | 295,313 | 301,236 | 123,469 | 119,781 |
| Preferred stock, value-Series ANon Voting Convertible Preferred Stock | 29,190 | 53,830 | 53,830 | 53,830 |
| Preferred stock, value | - | - | - | 0 |
| Preferred stock, value-Series BNon Voting Convertible Preferred Stock | 35,563 | 35,563 | 54,085 | 54,085 |
| Common stock, 0.001 par value 300,000,000 shares authorized 170,773,803 and 160,980,024 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 171 | 161 | 141 | 114 |
| Additional paid-in capital | 1,828,956 | 1,734,882 | 1,280,128 | 1,051,992 |
| Accumulated other comprehensive income (loss) | -415 | 355 | 208 | 13 |
| Accumulated deficit | -1,285,772 | -1,188,420 | -1,085,928 | -1,004,998 |
| Total stockholders equity | 607,693 | 636,371 | 302,464 | 155,036 |
| Total liabilities and stockholders equity | 903,006 | 937,607 | 425,933 | 274,817 |
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT)